BCM
IRD

BIOS Capital Management’s Opus Genetics IRD Stock Holding History

BIOS Capital Management’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.8M Hold
3,683,429
– – 31.7% 2
2025
Q4 		$7.4M Hold
3,683,429
– – 8.96% 3
2025
Q3 		$6.59M Hold
3,683,429
– – 7.42% 3
2025
Q2 		$3.46M Buy
3,683,429
+2,688,180
+270% +$2.49M 4.77% 2
2025
Q1 		$977K Hold
995,249
– – 1.23% 6
2024
Q4 		$1.18M Buy
+995,249
New +$1.14M 1.26% 6

Other funds holding IRD

CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return